- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04705623
Influence of Iyengar Yoga on the Bio-functional Age of Postmenopausal Women (IIYBFAPW)
A Single-center, Randomized, Controlled, Open-labelled, Two-armed, Interventional Clinical Trial Investigating the Effect of a 12 Week Iyengar Yoga Intervention on the Bio-functional Age of Postmenopausal Women.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Postmenopausal women qualifying as participants for the study are patients at the Universitätsklinik für Frauenheilkunde in Bern or are recruited through public advertisement. After giving informed consent the patients will be screened for inclusion and exclusion criteria and their biofunctional Status will be assessed. The participants of the study will then be randomly assigned to the intervention group (12 week yoga program) or to the control group. In addition to the 90 minutes yoga sessions instructed by a professional yoga teacher, the participants of the intervention group are asked to perform two yoga sessions lasting 45 minutes per week at home and document these in a diary.
After the 12 weeks the biofunctional Status of all participants of the study will be reassessed.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Petra o Stute, Prof. Dr. med
- Phone Number: +41 31 63 2 13 33
- Email: petra.stute@insel.ch
Study Contact Backup
- Name: Natascha Rieben, Study Nurse
- Phone Number: 0316321327
- Email: natascha.rieben@insel.ch
Study Locations
-
-
-
Berne, Switzerland, 3010
- Recruiting
- Dep. of Obstetrics and Gynecology, Bern University Hospital, Bern
-
Contact:
- Petra Stute, MD
- Phone Number: +41 31 63 2 13 33
- Email: petra.stute@insel.ch
-
Contact:
- Lara Schmid, study nurse
- Phone Number: 0316321303
- Email: lara.schmid@insel.ch
-
Principal Investigator:
- Petra Stute, M.D.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Informed consent
- Women after Menopause (defined as 12 months of spontaneous amenorrhea or 6 months of spontaneous amenorrhea with serum FSH levels >40mlU/ml or 6 weeks postsurgical bilateral oophorectomy with or without hysterectomy)
- Age over 18 years
- At least 4 hot flushes per day (examined through the Menopause rating scale MRS-II)
- No regular yoga practice for two years
- German as native language
- Willing to participate in 12 yoga classes as well as two 45 self practice sessions per week
- Willing to assess biofunctional Status and give blood samples
Exclusion Criteria:
- Acute and/or serious disease in the past two years (e.g. Cancer, major surgery)
- Autoimmune or chronic inflammatory disease (e.g. rheumatism, thyroid dysfunction)
- Mental illness (e.g. Depression or anxiety disorder (HADS >8))
- Acute or chronic back pain or herniated vertebral disc
- Compulsion to participate in the trial
- Attendance of less than 10 yoga lessons out of 12.
- Hormone replacement therapy (HRT)
- Smoking > 20 Cigarettes per day or over 20 packyears
- Consumption of >30g alcohol per day (>1 liter of beer or >0.3 dl of wine)
- Previous periodic participation in yoga classes within the last two years
- Inability or contraindications to undergo the investigated intervention
- Participants incapable of judgement or participants under tutelage Diabetes mellitus
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention
The intervention group receives weekly 90 minute yoga classes over a course of 12 weeks.
They are also asked to do two 45-minute yoga classes at home each week and document these in a Diary.
|
Weekly 90 minute Iyengar Yoga classes taught y a professional instructor.
Twice weekly 45 minute self practice of Iyengar Yoga at home by the participants
|
No Intervention: Control
The control group receives an assessment of their biofunctional status at the beginning and the end of the study (same as the intervention group).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Decrease of the biofunctional age (BFA) through a 12 week Iyengar yoga intervention compared to the control group with no yoga classes. In order to evaluate the BFA a biofunctional Status (BFS) has to be assessed.
Time Frame: 12 weeks
|
The BFS is a generic, age- and sex-specific test battery comprising holistic characteristics from physical, mental-emotional and social areas.
The single values of the BFS test battery were scaled and differentiated for chronological age (CA) and sex.
Their summation makes up the so-called Bio-functional Age Index BFAI (BFAI = Σ (B-X/B-L)n/n).
The BFAI is a relative measure compared to a reference population, out of which norm charts were developed.
By definition, the reference population's BFAI is identical with its CA.
A BFAI of an individual may be transformed into BFA (years) by means of gerontologic aging tables.
This BFA (years) relates to the mean value of a certain CA.
The BFA is based on a sex-specific regression and factor analysis of functional age (Mathieu et al., 2018.
Illness perception in overweight and obesity and impact on bio-functional age.
Archives of gynecology and obstetrics, 298(2), p. 417)
|
12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Hot flushes
Time Frame: 12 weeks
|
Change of the climacteric symptom hot flushes (number per day) measured at the beginning and after 12 weeks of the intervention
|
12 weeks
|
Level of High sensitive C-reactive protein (HS-CRP)
Time Frame: 12 weeks
|
Change of the climacteric symptom Level of HS-CRP (mg/l) measured at the beginning and after 12 weeks of the intervention
|
12 weeks
|
Oxidative balance
Time Frame: 12 weeks
|
Change of the climacteric symptom oxidative balance measured at the beginning and after 12 weeks of the intervention
|
12 weeks
|
Collaborators and Investigators
Investigators
- Principal Investigator: Petra Stute, Prof. Dr. med, Universitätsklinik für Frauenheilkunde Bern
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2019-01794
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Postmenopausal
-
Fundació EurecatCompletedMenopause | Postmenopausal Symptoms | Postmenopausal DisorderSpain
-
Hend HamdyNot yet recruiting
-
University of Erlangen-Nürnberg Medical SchoolElsbeth-Bonhoff-Stiftung, BerlinTerminatedPostmenopausalGermany
-
Warner ChilcottSanofiCompletedPostmenopausalUnited States, Poland, Canada, Croatia, Netherlands
-
Mayo ClinicCompletedPostmenopausalUnited States
-
Riphah International UniversityCompletedPostmenopausal Osteoporosis | Postmenopausal OsteopeniaPakistan
-
AmgenCompletedPostmenopausal Osteoporosis (PMO)Japan
-
Cairo Universityfaculty of physical therapyCompletedPostmenopausal DisorderEgypt
-
Chong Kun Dang PharmaceuticalSeverance HospitalCompleted
-
University of Sao PauloAlzChem AGUnknown
Clinical Trials on Iyengar Yoga
-
University of Illinois at Urbana-ChampaignUnknownPolycystic Ovary Syndrome | Endometriosis | Dysmenorrhea | Menstrual Pain | Fibroid | Menstrual Discomfort | Dysmenorrhea Secondary | Secondary Dysmenorrhea | Menstrual DisorderUnited States
-
Ziauddin UniversityCompletedEffects of Iyengar Yoga Therapy in the Management of Stress Urinary Incontinence Among Young FemalesStress Urinary IncontinencePakistan
-
Hospital Israelita Albert EinsteinActive, not recruitingMultiple SclerosisBrazil
-
University of California, Los AngelesCompleted
-
Manhattan Physical Medicine and Rehabilitation,...New York UniversityCompleted
-
Charite University, Berlin, GermanyRecruiting
-
University of California, Los AngelesCompleted
-
Charite University, Berlin, GermanyCompleted
-
Medical College of WisconsinRecruiting
-
University of Wisconsin, MadisonAmerican College of Sports MedicineCompletedBreast Cancer | Neuropathic Pain | Chemotherapy-induced Peripheral NeuropathyUnited States